Atara Biotherapeutics, Inc.

Q2 2021 vs. Q3 2021 13F Holders

Period
Q2 2021
Q3 2021
Num holders
148
143
Total reported value, excl. options
$1.34 B
$1.61 B
Total shares, excl. options
85,985,246
89,699,088
Manager Q2 2021
Shares
Q3 2021
Shares
Diff Chg %